Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Olokizumab Olokizumab 💬African trypanosomiasis
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
2 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬African trypanosomiasis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬2. African trypanosomiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
3 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pomalidomide Pomalidomide 💬African trypanosomiasis
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬3. African trypanosomiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
4 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Siltuximab Siltuximab 💬African trypanosomiasis
| Siltuximab | 028 [2] 28, 331 💬4. African trypanosomiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
5 | African trypanosomiasis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Sirukumab Sirukumab 💬African trypanosomiasis
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
6 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Olokizumab Olokizumab 💬AGE-RAGE signaling pathway in diabetic complications
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
7 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬AGE-RAGE signaling pathway in diabetic complications
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬7. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
8 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pomalidomide Pomalidomide 💬AGE-RAGE signaling pathway in diabetic complications
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬8. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
9 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Siltuximab Siltuximab 💬AGE-RAGE signaling pathway in diabetic complications
| Siltuximab | 028 [2] 28, 331 💬9. AGE-RAGE signaling pathway in diabetic complications
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
10 | AGE-RAGE signaling pathway in diabetic complications 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Sirukumab Sirukumab 💬AGE-RAGE signaling pathway in diabetic complications
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
11 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Olokizumab Olokizumab 💬Alcoholic liver disease
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Alcoholic liver disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬12. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
13 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pomalidomide Pomalidomide 💬Alcoholic liver disease
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬13. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
14 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Siltuximab Siltuximab 💬Alcoholic liver disease
| Siltuximab | 028 [2] 28, 331 💬14. Alcoholic liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 | Alcoholic liver disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Sirukumab Sirukumab 💬Alcoholic liver disease
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
16 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Olokizumab Olokizumab 💬Alzheimer disease
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
17 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Alzheimer disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬17. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
18 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pomalidomide Pomalidomide 💬Alzheimer disease
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬18. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
19 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Siltuximab Siltuximab 💬Alzheimer disease
| Siltuximab | 028 [2] 28, 331 💬19. Alzheimer disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
20 | Alzheimer disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Sirukumab Sirukumab 💬Alzheimer disease
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
21 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Olokizumab Olokizumab 💬Amoebiasis
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
22 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Amoebiasis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬22. Amoebiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
23 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pomalidomide Pomalidomide 💬Amoebiasis
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬23. Amoebiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
24 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Siltuximab Siltuximab 💬Amoebiasis
| Siltuximab | 028 [2] 28, 331 💬24. Amoebiasis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
25 | Amoebiasis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Sirukumab Sirukumab 💬Amoebiasis
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
26 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Olokizumab Olokizumab 💬C-type lectin receptor signaling pathway
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
27 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬C-type lectin receptor signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬27. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
28 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pomalidomide Pomalidomide 💬C-type lectin receptor signaling pathway
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬28. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
29 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Siltuximab Siltuximab 💬C-type lectin receptor signaling pathway
| Siltuximab | 028 [2] 28, 331 💬29. C-type lectin receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
30 | C-type lectin receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Sirukumab Sirukumab 💬C-type lectin receptor signaling pathway
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
31 | Cellular senescence 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Olokizumab Olokizumab 💬Cellular senescence
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
32 | Cellular senescence 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Cellular senescence
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬32. Cellular senescence
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
33 | Cellular senescence 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pomalidomide Pomalidomide 💬Cellular senescence
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬33. Cellular senescence
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
34 | Cellular senescence 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Siltuximab Siltuximab 💬Cellular senescence
| Siltuximab | 028 [2] 28, 331 💬34. Cellular senescence
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
35 | Cellular senescence 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Sirukumab Sirukumab 💬Cellular senescence
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
36 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Olokizumab Olokizumab 💬Chagas disease
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
37 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Chagas disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬37. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
38 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pomalidomide Pomalidomide 💬Chagas disease
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬38. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
39 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Siltuximab Siltuximab 💬Chagas disease
| Siltuximab | 028 [2] 28, 331 💬39. Chagas disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
40 | Chagas disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Sirukumab Sirukumab 💬Chagas disease
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
41 | Coronavirus disease - COVID-19 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Olokizumab Olokizumab 💬Coronavirus disease - COVID-19
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
42 | Coronavirus disease - COVID-19 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pirfenidone Pirfenidone 💬Coronavirus disease - COVID-19
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬42. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
43 | Coronavirus disease - COVID-19 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Pomalidomide Pomalidomide 💬Coronavirus disease - COVID-19
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬43. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
44 | Coronavirus disease - COVID-19 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Siltuximab Siltuximab 💬Coronavirus disease - COVID-19
| Siltuximab | 028 [2] 28, 331 💬44. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
45 | Coronavirus disease - COVID-19 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬African trypanosomiasis
|
Sirukumab Sirukumab 💬Coronavirus disease - COVID-19
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
46 | Coronavirus disease - COVID-19 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Sarilumab Sarilumab 💬Coronavirus disease - COVID-19
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬46. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
47 | Coronavirus disease - COVID-19 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Satralizumab Satralizumab 💬Coronavirus disease - COVID-19
| Satralizumab | 011 [4] 11, 13, 86, 113 💬47. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
48 | Coronavirus disease - COVID-19 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Coronavirus disease - COVID-19
|
Tocilizumab Tocilizumab 💬Coronavirus disease - COVID-19
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬48. Coronavirus disease - COVID-19
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
49 | Cytokine-cytokine receptor interaction 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Cytokine-cytokine receptor interaction
|
Olokizumab Olokizumab 💬Cytokine-cytokine receptor interaction
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
50 | Cytokine-cytokine receptor interaction 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Cytokine-cytokine receptor interaction
|
Pirfenidone Pirfenidone 💬Cytokine-cytokine receptor interaction
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬50. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
51 | Cytokine-cytokine receptor interaction 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Cytokine-cytokine receptor interaction
|
Pomalidomide Pomalidomide 💬Cytokine-cytokine receptor interaction
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬51. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
52 | Cytokine-cytokine receptor interaction 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Cytokine-cytokine receptor interaction
|
Siltuximab Siltuximab 💬Cytokine-cytokine receptor interaction
| Siltuximab | 028 [2] 28, 331 💬52. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
53 | Cytokine-cytokine receptor interaction 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Cytokine-cytokine receptor interaction
|
Sirukumab Sirukumab 💬Cytokine-cytokine receptor interaction
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
54 | Cytokine-cytokine receptor interaction 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Cytokine-cytokine receptor interaction
|
Sarilumab Sarilumab 💬Cytokine-cytokine receptor interaction
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬54. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
55 | Cytokine-cytokine receptor interaction 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Cytokine-cytokine receptor interaction
|
Satralizumab Satralizumab 💬Cytokine-cytokine receptor interaction
| Satralizumab | 011 [4] 11, 13, 86, 113 💬55. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
56 | Cytokine-cytokine receptor interaction 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Cytokine-cytokine receptor interaction
|
Tocilizumab Tocilizumab 💬Cytokine-cytokine receptor interaction
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬56. Cytokine-cytokine receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
57 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Olokizumab Olokizumab 💬Cytosolic DNA-sensing pathway
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
58 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Pirfenidone Pirfenidone 💬Cytosolic DNA-sensing pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬58. Cytosolic DNA-sensing pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
59 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Pomalidomide Pomalidomide 💬Cytosolic DNA-sensing pathway
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬59. Cytosolic DNA-sensing pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
60 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Siltuximab Siltuximab 💬Cytosolic DNA-sensing pathway
| Siltuximab | 028 [2] 28, 331 💬60. Cytosolic DNA-sensing pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
61 | Cytosolic DNA-sensing pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Sirukumab Sirukumab 💬Cytosolic DNA-sensing pathway
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
62 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Olokizumab Olokizumab 💬Epstein-Barr virus infection
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
63 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Pirfenidone Pirfenidone 💬Epstein-Barr virus infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬63. Epstein-Barr virus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
64 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Pomalidomide Pomalidomide 💬Epstein-Barr virus infection
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬64. Epstein-Barr virus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
65 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Siltuximab Siltuximab 💬Epstein-Barr virus infection
| Siltuximab | 028 [2] 28, 331 💬65. Epstein-Barr virus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
66 | Epstein-Barr virus infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Sirukumab Sirukumab 💬Epstein-Barr virus infection
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
67 | FoxO signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Olokizumab Olokizumab 💬FoxO signaling pathway
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
68 | FoxO signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Pirfenidone Pirfenidone 💬FoxO signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬68. FoxO signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
69 | FoxO signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Pomalidomide Pomalidomide 💬FoxO signaling pathway
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬69. FoxO signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
70 | FoxO signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Siltuximab Siltuximab 💬FoxO signaling pathway
| Siltuximab | 028 [2] 28, 331 💬70. FoxO signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
71 | FoxO signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Sirukumab Sirukumab 💬FoxO signaling pathway
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
72 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Olokizumab Olokizumab 💬Graft-versus-host disease
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
73 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Pirfenidone Pirfenidone 💬Graft-versus-host disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬73. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
74 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Pomalidomide Pomalidomide 💬Graft-versus-host disease
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬74. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
75 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Siltuximab Siltuximab 💬Graft-versus-host disease
| Siltuximab | 028 [2] 28, 331 💬75. Graft-versus-host disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
76 | Graft-versus-host disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Sirukumab Sirukumab 💬Graft-versus-host disease
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
77 | Hematopoietic cell lineage 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Olokizumab Olokizumab 💬Hematopoietic cell lineage
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
78 | Hematopoietic cell lineage 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Pirfenidone Pirfenidone 💬Hematopoietic cell lineage
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬78. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
79 | Hematopoietic cell lineage 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Pomalidomide Pomalidomide 💬Hematopoietic cell lineage
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬79. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
80 | Hematopoietic cell lineage 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Siltuximab Siltuximab 💬Hematopoietic cell lineage
| Siltuximab | 028 [2] 28, 331 💬80. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
81 | Hematopoietic cell lineage 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Cytosolic DNA-sensing pathway
|
Sirukumab Sirukumab 💬Hematopoietic cell lineage
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
82 | Hematopoietic cell lineage 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Hematopoietic cell lineage
|
Sarilumab Sarilumab 💬Hematopoietic cell lineage
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬82. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
83 | Hematopoietic cell lineage 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Hematopoietic cell lineage
|
Satralizumab Satralizumab 💬Hematopoietic cell lineage
| Satralizumab | 011 [4] 11, 13, 86, 113 💬83. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
84 | Hematopoietic cell lineage 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Hematopoietic cell lineage
|
Tocilizumab Tocilizumab 💬Hematopoietic cell lineage
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬84. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
85 | Hepatitis B 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Hepatitis B
|
Olokizumab Olokizumab 💬Hepatitis B
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
86 | Hepatitis B 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Hepatitis B
|
Pirfenidone Pirfenidone 💬Hepatitis B
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬86. Hepatitis B
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
87 | Hepatitis B 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Hepatitis B
|
Pomalidomide Pomalidomide 💬Hepatitis B
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬87. Hepatitis B
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
88 | Hepatitis B 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Hepatitis B
|
Siltuximab Siltuximab 💬Hepatitis B
| Siltuximab | 028 [2] 28, 331 💬88. Hepatitis B
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
89 | Hepatitis B 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Hepatitis B
|
Sirukumab Sirukumab 💬Hepatitis B
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
90 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Hepatitis B
|
Olokizumab Olokizumab 💬Herpes simplex virus 1 infection
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
91 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Hepatitis B
|
Pirfenidone Pirfenidone 💬Herpes simplex virus 1 infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬91. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
92 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Hepatitis B
|
Pomalidomide Pomalidomide 💬Herpes simplex virus 1 infection
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬92. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
93 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Hepatitis B
|
Siltuximab Siltuximab 💬Herpes simplex virus 1 infection
| Siltuximab | 028 [2] 28, 331 💬93. Herpes simplex virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
94 | Herpes simplex virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Hepatitis B
|
Sirukumab Sirukumab 💬Herpes simplex virus 1 infection
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
95 | HIF-1 signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Hepatitis B
|
Olokizumab Olokizumab 💬HIF-1 signaling pathway
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
96 | HIF-1 signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Hepatitis B
|
Pirfenidone Pirfenidone 💬HIF-1 signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬96. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
97 | HIF-1 signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Hepatitis B
|
Pomalidomide Pomalidomide 💬HIF-1 signaling pathway
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬97. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
98 | HIF-1 signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Hepatitis B
|
Siltuximab Siltuximab 💬HIF-1 signaling pathway
| Siltuximab | 028 [2] 28, 331 💬98. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
99 | HIF-1 signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Hepatitis B
|
Sirukumab Sirukumab 💬HIF-1 signaling pathway
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
100 | HIF-1 signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬HIF-1 signaling pathway
|
Sarilumab Sarilumab 💬HIF-1 signaling pathway
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬100. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
101 | HIF-1 signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬HIF-1 signaling pathway
|
Satralizumab Satralizumab 💬HIF-1 signaling pathway
| Satralizumab | 011 [4] 11, 13, 86, 113 💬101. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
102 | HIF-1 signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬HIF-1 signaling pathway
|
Tocilizumab Tocilizumab 💬HIF-1 signaling pathway
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬102. HIF-1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
103 | Human cytomegalovirus infection 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Human cytomegalovirus infection
|
Olokizumab Olokizumab 💬Human cytomegalovirus infection
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
104 | Human cytomegalovirus infection 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Human cytomegalovirus infection
|
Pirfenidone Pirfenidone 💬Human cytomegalovirus infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬104. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
105 | Human cytomegalovirus infection 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Human cytomegalovirus infection
|
Pomalidomide Pomalidomide 💬Human cytomegalovirus infection
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬105. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
106 | Human cytomegalovirus infection 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Human cytomegalovirus infection
|
Siltuximab Siltuximab 💬Human cytomegalovirus infection
| Siltuximab | 028 [2] 28, 331 💬106. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
107 | Human cytomegalovirus infection 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Human cytomegalovirus infection
|
Sirukumab Sirukumab 💬Human cytomegalovirus infection
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
108 | Human cytomegalovirus infection 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Human cytomegalovirus infection
|
Sarilumab Sarilumab 💬Human cytomegalovirus infection
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬108. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
109 | Human cytomegalovirus infection 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Human cytomegalovirus infection
|
Satralizumab Satralizumab 💬Human cytomegalovirus infection
| Satralizumab | 011 [4] 11, 13, 86, 113 💬109. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
110 | Human cytomegalovirus infection 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Human cytomegalovirus infection
|
Tocilizumab Tocilizumab 💬Human cytomegalovirus infection
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬110. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
111 | Human T-cell leukemia virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Olokizumab Olokizumab 💬Human T-cell leukemia virus 1 infection
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
112 | Human T-cell leukemia virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pirfenidone Pirfenidone 💬Human T-cell leukemia virus 1 infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬112. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
113 | Human T-cell leukemia virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pomalidomide Pomalidomide 💬Human T-cell leukemia virus 1 infection
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬113. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
114 | Human T-cell leukemia virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Siltuximab Siltuximab 💬Human T-cell leukemia virus 1 infection
| Siltuximab | 028 [2] 28, 331 💬114. Human T-cell leukemia virus 1 infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
115 | Human T-cell leukemia virus 1 infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Sirukumab Sirukumab 💬Human T-cell leukemia virus 1 infection
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
116 | Hypertrophic cardiomyopathy 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Olokizumab Olokizumab 💬Hypertrophic cardiomyopathy
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
117 | Hypertrophic cardiomyopathy 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pirfenidone Pirfenidone 💬Hypertrophic cardiomyopathy
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬117. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
118 | Hypertrophic cardiomyopathy 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pomalidomide Pomalidomide 💬Hypertrophic cardiomyopathy
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬118. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
119 | Hypertrophic cardiomyopathy 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Siltuximab Siltuximab 💬Hypertrophic cardiomyopathy
| Siltuximab | 028 [2] 28, 331 💬119. Hypertrophic cardiomyopathy
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
120 | Hypertrophic cardiomyopathy 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Sirukumab Sirukumab 💬Hypertrophic cardiomyopathy
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
121 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Olokizumab Olokizumab 💬IL-17 signaling pathway
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
122 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pirfenidone Pirfenidone 💬IL-17 signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬122. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
123 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pomalidomide Pomalidomide 💬IL-17 signaling pathway
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬123. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
124 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Siltuximab Siltuximab 💬IL-17 signaling pathway
| Siltuximab | 028 [2] 28, 331 💬124. IL-17 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
125 | IL-17 signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Sirukumab Sirukumab 💬IL-17 signaling pathway
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
126 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Olokizumab Olokizumab 💬Inflammatory bowel disease
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
127 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pirfenidone Pirfenidone 💬Inflammatory bowel disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬127. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
128 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pomalidomide Pomalidomide 💬Inflammatory bowel disease
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬128. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
129 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Siltuximab Siltuximab 💬Inflammatory bowel disease
| Siltuximab | 028 [2] 28, 331 💬129. Inflammatory bowel disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
130 | Inflammatory bowel disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Sirukumab Sirukumab 💬Inflammatory bowel disease
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
131 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Olokizumab Olokizumab 💬Influenza A
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
132 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pirfenidone Pirfenidone 💬Influenza A
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬132. Influenza A
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
133 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pomalidomide Pomalidomide 💬Influenza A
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬133. Influenza A
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
134 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Siltuximab Siltuximab 💬Influenza A
| Siltuximab | 028 [2] 28, 331 💬134. Influenza A
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
135 | Influenza A 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Sirukumab Sirukumab 💬Influenza A
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
136 | Insulin resistance 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Olokizumab Olokizumab 💬Insulin resistance
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
137 | Insulin resistance 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pirfenidone Pirfenidone 💬Insulin resistance
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬137. Insulin resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
138 | Insulin resistance 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pomalidomide Pomalidomide 💬Insulin resistance
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬138. Insulin resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
139 | Insulin resistance 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Siltuximab Siltuximab 💬Insulin resistance
| Siltuximab | 028 [2] 28, 331 💬139. Insulin resistance
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
140 | Insulin resistance 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Sirukumab Sirukumab 💬Insulin resistance
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
141 | Intestinal immune network for IgA production 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Olokizumab Olokizumab 💬Intestinal immune network for IgA production
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
142 | Intestinal immune network for IgA production 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pirfenidone Pirfenidone 💬Intestinal immune network for IgA production
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬142. Intestinal immune network for IgA production
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
143 | Intestinal immune network for IgA production 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pomalidomide Pomalidomide 💬Intestinal immune network for IgA production
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬143. Intestinal immune network for IgA production
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
144 | Intestinal immune network for IgA production 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Siltuximab Siltuximab 💬Intestinal immune network for IgA production
| Siltuximab | 028 [2] 28, 331 💬144. Intestinal immune network for IgA production
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
145 | Intestinal immune network for IgA production 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Sirukumab Sirukumab 💬Intestinal immune network for IgA production
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
146 | JAK-STAT signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Olokizumab Olokizumab 💬JAK-STAT signaling pathway
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
147 | JAK-STAT signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pirfenidone Pirfenidone 💬JAK-STAT signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬147. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
148 | JAK-STAT signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Pomalidomide Pomalidomide 💬JAK-STAT signaling pathway
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬148. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
149 | JAK-STAT signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Siltuximab Siltuximab 💬JAK-STAT signaling pathway
| Siltuximab | 028 [2] 28, 331 💬149. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
150 | JAK-STAT signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Human T-cell leukemia virus 1 infection
|
Sirukumab Sirukumab 💬JAK-STAT signaling pathway
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
151 | JAK-STAT signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬JAK-STAT signaling pathway
|
Sarilumab Sarilumab 💬JAK-STAT signaling pathway
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬151. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
152 | JAK-STAT signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬JAK-STAT signaling pathway
|
Satralizumab Satralizumab 💬JAK-STAT signaling pathway
| Satralizumab | 011 [4] 11, 13, 86, 113 💬152. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
153 | JAK-STAT signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬JAK-STAT signaling pathway
|
Tocilizumab Tocilizumab 💬JAK-STAT signaling pathway
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬153. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
154 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Olokizumab Olokizumab 💬Kaposi sarcoma-associated herpesvirus infection
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
155 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Pirfenidone Pirfenidone 💬Kaposi sarcoma-associated herpesvirus infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬155. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
156 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Pomalidomide Pomalidomide 💬Kaposi sarcoma-associated herpesvirus infection
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬156. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
157 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Siltuximab Siltuximab 💬Kaposi sarcoma-associated herpesvirus infection
| Siltuximab | 028 [2] 28, 331 💬157. Kaposi sarcoma-associated herpesvirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
158 | Kaposi sarcoma-associated herpesvirus infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Sirukumab Sirukumab 💬Kaposi sarcoma-associated herpesvirus infection
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
159 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Olokizumab Olokizumab 💬Legionellosis
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
160 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Pirfenidone Pirfenidone 💬Legionellosis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬160. Legionellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
161 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Pomalidomide Pomalidomide 💬Legionellosis
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬161. Legionellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
162 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Siltuximab Siltuximab 💬Legionellosis
| Siltuximab | 028 [2] 28, 331 💬162. Legionellosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
163 | Legionellosis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Sirukumab Sirukumab 💬Legionellosis
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
164 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Olokizumab Olokizumab 💬Lipid and atherosclerosis
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
165 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Pirfenidone Pirfenidone 💬Lipid and atherosclerosis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬165. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
166 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Pomalidomide Pomalidomide 💬Lipid and atherosclerosis
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬166. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
167 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Siltuximab Siltuximab 💬Lipid and atherosclerosis
| Siltuximab | 028 [2] 28, 331 💬167. Lipid and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
168 | Lipid and atherosclerosis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Sirukumab Sirukumab 💬Lipid and atherosclerosis
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
169 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Olokizumab Olokizumab 💬Malaria
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
170 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Pirfenidone Pirfenidone 💬Malaria
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬170. Malaria
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
171 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Pomalidomide Pomalidomide 💬Malaria
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬171. Malaria
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
172 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Siltuximab Siltuximab 💬Malaria
| Siltuximab | 028 [2] 28, 331 💬172. Malaria
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
173 | Malaria 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Sirukumab Sirukumab 💬Malaria
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
174 | Measles 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Olokizumab Olokizumab 💬Measles
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
175 | Measles 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Pirfenidone Pirfenidone 💬Measles
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬175. Measles
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
176 | Measles 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Pomalidomide Pomalidomide 💬Measles
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬176. Measles
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
177 | Measles 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Siltuximab Siltuximab 💬Measles
| Siltuximab | 028 [2] 28, 331 💬177. Measles
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
178 | Measles 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Sirukumab Sirukumab 💬Measles
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
179 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Olokizumab Olokizumab 💬NOD-like receptor signaling pathway
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
180 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Pirfenidone Pirfenidone 💬NOD-like receptor signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬180. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
181 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Pomalidomide Pomalidomide 💬NOD-like receptor signaling pathway
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬181. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
182 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Siltuximab Siltuximab 💬NOD-like receptor signaling pathway
| Siltuximab | 028 [2] 28, 331 💬182. NOD-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
183 | NOD-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Sirukumab Sirukumab 💬NOD-like receptor signaling pathway
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
184 | Non-alcoholic fatty liver disease 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Olokizumab Olokizumab 💬Non-alcoholic fatty liver disease
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
185 | Non-alcoholic fatty liver disease 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Pirfenidone Pirfenidone 💬Non-alcoholic fatty liver disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬185. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
186 | Non-alcoholic fatty liver disease 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Pomalidomide Pomalidomide 💬Non-alcoholic fatty liver disease
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬186. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
187 | Non-alcoholic fatty liver disease 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Siltuximab Siltuximab 💬Non-alcoholic fatty liver disease
| Siltuximab | 028 [2] 28, 331 💬187. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
188 | Non-alcoholic fatty liver disease 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Kaposi sarcoma-associated herpesvirus infection
|
Sirukumab Sirukumab 💬Non-alcoholic fatty liver disease
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
189 | Non-alcoholic fatty liver disease 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Non-alcoholic fatty liver disease
|
Sarilumab Sarilumab 💬Non-alcoholic fatty liver disease
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬189. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
190 | Non-alcoholic fatty liver disease 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Non-alcoholic fatty liver disease
|
Satralizumab Satralizumab 💬Non-alcoholic fatty liver disease
| Satralizumab | 011 [4] 11, 13, 86, 113 💬190. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
191 | Non-alcoholic fatty liver disease 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Non-alcoholic fatty liver disease
|
Tocilizumab Tocilizumab 💬Non-alcoholic fatty liver disease
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬191. Non-alcoholic fatty liver disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
192 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Pathogenic Escherichia coli infection
|
Olokizumab Olokizumab 💬Pathogenic Escherichia coli infection
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
193 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Pathogenic Escherichia coli infection
|
Pirfenidone Pirfenidone 💬Pathogenic Escherichia coli infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬193. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
194 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Pathogenic Escherichia coli infection
|
Pomalidomide Pomalidomide 💬Pathogenic Escherichia coli infection
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬194. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
195 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Pathogenic Escherichia coli infection
|
Siltuximab Siltuximab 💬Pathogenic Escherichia coli infection
| Siltuximab | 028 [2] 28, 331 💬195. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
196 | Pathogenic Escherichia coli infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Pathogenic Escherichia coli infection
|
Sirukumab Sirukumab 💬Pathogenic Escherichia coli infection
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
197 | Pathways in cancer 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Pathogenic Escherichia coli infection
|
Olokizumab Olokizumab 💬Pathways in cancer
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
198 | Pathways in cancer 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Pathogenic Escherichia coli infection
|
Pirfenidone Pirfenidone 💬Pathways in cancer
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬198. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
199 | Pathways in cancer 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Pathogenic Escherichia coli infection
|
Pomalidomide Pomalidomide 💬Pathways in cancer
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬199. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
200 | Pathways in cancer 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Pathogenic Escherichia coli infection
|
Siltuximab Siltuximab 💬Pathways in cancer
| Siltuximab | 028 [2] 28, 331 💬200. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
201 | Pathways in cancer 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Pathogenic Escherichia coli infection
|
Sirukumab Sirukumab 💬Pathways in cancer
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
202 | Pathways in cancer 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Pathways in cancer
|
Sarilumab Sarilumab 💬Pathways in cancer
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬202. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
203 | Pathways in cancer 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Pathways in cancer
|
Satralizumab Satralizumab 💬Pathways in cancer
| Satralizumab | 011 [4] 11, 13, 86, 113 💬203. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
204 | Pathways in cancer 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Pathways in cancer
|
Tocilizumab Tocilizumab 💬Pathways in cancer
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬204. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
205 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Pathways of neurodegeneration - multiple diseases
|
Olokizumab Olokizumab 💬Pathways of neurodegeneration - multiple diseases
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
206 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Pathways of neurodegeneration - multiple diseases
|
Pirfenidone Pirfenidone 💬Pathways of neurodegeneration - multiple diseases
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬206. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
207 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Pathways of neurodegeneration - multiple diseases
|
Pomalidomide Pomalidomide 💬Pathways of neurodegeneration - multiple diseases
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬207. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
208 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Pathways of neurodegeneration - multiple diseases
|
Siltuximab Siltuximab 💬Pathways of neurodegeneration - multiple diseases
| Siltuximab | 028 [2] 28, 331 💬208. Pathways of neurodegeneration - multiple diseases
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
209 | Pathways of neurodegeneration - multiple diseases 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Pathways of neurodegeneration - multiple diseases
|
Sirukumab Sirukumab 💬Pathways of neurodegeneration - multiple diseases
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
210 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Pathways of neurodegeneration - multiple diseases
|
Olokizumab Olokizumab 💬Pertussis
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
211 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Pathways of neurodegeneration - multiple diseases
|
Pirfenidone Pirfenidone 💬Pertussis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬211. Pertussis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
212 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Pathways of neurodegeneration - multiple diseases
|
Pomalidomide Pomalidomide 💬Pertussis
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬212. Pertussis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
213 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Pathways of neurodegeneration - multiple diseases
|
Siltuximab Siltuximab 💬Pertussis
| Siltuximab | 028 [2] 28, 331 💬213. Pertussis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
214 | Pertussis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Pathways of neurodegeneration - multiple diseases
|
Sirukumab Sirukumab 💬Pertussis
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
215 | PI3K-Akt signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Pathways of neurodegeneration - multiple diseases
|
Olokizumab Olokizumab 💬PI3K-Akt signaling pathway
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
216 | PI3K-Akt signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Pathways of neurodegeneration - multiple diseases
|
Pirfenidone Pirfenidone 💬PI3K-Akt signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬216. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
217 | PI3K-Akt signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Pathways of neurodegeneration - multiple diseases
|
Pomalidomide Pomalidomide 💬PI3K-Akt signaling pathway
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬217. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
218 | PI3K-Akt signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Pathways of neurodegeneration - multiple diseases
|
Siltuximab Siltuximab 💬PI3K-Akt signaling pathway
| Siltuximab | 028 [2] 28, 331 💬218. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
219 | PI3K-Akt signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Pathways of neurodegeneration - multiple diseases
|
Sirukumab Sirukumab 💬PI3K-Akt signaling pathway
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
220 | PI3K-Akt signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬PI3K-Akt signaling pathway
|
Sarilumab Sarilumab 💬PI3K-Akt signaling pathway
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬220. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
221 | PI3K-Akt signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬PI3K-Akt signaling pathway
|
Satralizumab Satralizumab 💬PI3K-Akt signaling pathway
| Satralizumab | 011 [4] 11, 13, 86, 113 💬221. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
222 | PI3K-Akt signaling pathway 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬PI3K-Akt signaling pathway
|
Tocilizumab Tocilizumab 💬PI3K-Akt signaling pathway
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬222. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
223 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Prion disease
|
Olokizumab Olokizumab 💬Prion disease
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
224 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Prion disease
|
Pirfenidone Pirfenidone 💬Prion disease
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬224. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
225 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Prion disease
|
Pomalidomide Pomalidomide 💬Prion disease
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬225. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
226 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Prion disease
|
Siltuximab Siltuximab 💬Prion disease
| Siltuximab | 028 [2] 28, 331 💬226. Prion disease
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
227 | Prion disease 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Prion disease
|
Sirukumab Sirukumab 💬Prion disease
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
228 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Prion disease
|
Olokizumab Olokizumab 💬Rheumatoid arthritis
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
229 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Prion disease
|
Pirfenidone Pirfenidone 💬Rheumatoid arthritis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬229. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
230 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Prion disease
|
Pomalidomide Pomalidomide 💬Rheumatoid arthritis
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬230. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
231 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Prion disease
|
Siltuximab Siltuximab 💬Rheumatoid arthritis
| Siltuximab | 028 [2] 28, 331 💬231. Rheumatoid arthritis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
232 | Rheumatoid arthritis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Prion disease
|
Sirukumab Sirukumab 💬Rheumatoid arthritis
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
233 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Prion disease
|
Olokizumab Olokizumab 💬Salmonella infection
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
234 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Prion disease
|
Pirfenidone Pirfenidone 💬Salmonella infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬234. Salmonella infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
235 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Prion disease
|
Pomalidomide Pomalidomide 💬Salmonella infection
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬235. Salmonella infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
236 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Prion disease
|
Siltuximab Siltuximab 💬Salmonella infection
| Siltuximab | 028 [2] 28, 331 💬236. Salmonella infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
237 | Salmonella infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Prion disease
|
Sirukumab Sirukumab 💬Salmonella infection
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
238 | Th17 cell differentiation 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Prion disease
|
Olokizumab Olokizumab 💬Th17 cell differentiation
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
239 | Th17 cell differentiation 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Prion disease
|
Pirfenidone Pirfenidone 💬Th17 cell differentiation
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬239. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
240 | Th17 cell differentiation 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Prion disease
|
Pomalidomide Pomalidomide 💬Th17 cell differentiation
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬240. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
241 | Th17 cell differentiation 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Prion disease
|
Siltuximab Siltuximab 💬Th17 cell differentiation
| Siltuximab | 028 [2] 28, 331 💬241. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
242 | Th17 cell differentiation 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬Prion disease
|
Sirukumab Sirukumab 💬Th17 cell differentiation
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
243 | Th17 cell differentiation 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Th17 cell differentiation
|
Sarilumab Sarilumab 💬Th17 cell differentiation
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬243. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
244 | Th17 cell differentiation 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Th17 cell differentiation
|
Satralizumab Satralizumab 💬Th17 cell differentiation
| Satralizumab | 011 [4] 11, 13, 86, 113 💬244. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
245 | Th17 cell differentiation 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Th17 cell differentiation
|
Tocilizumab Tocilizumab 💬Th17 cell differentiation
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬245. Th17 cell differentiation
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
246 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Olokizumab Olokizumab 💬TNF signaling pathway
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
247 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Pirfenidone Pirfenidone 💬TNF signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬247. TNF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
248 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Pomalidomide Pomalidomide 💬TNF signaling pathway
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬248. TNF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
249 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Siltuximab Siltuximab 💬TNF signaling pathway
| Siltuximab | 028 [2] 28, 331 💬249. TNF signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
250 | TNF signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Sirukumab Sirukumab 💬TNF signaling pathway
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
251 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Olokizumab Olokizumab 💬Toll-like receptor signaling pathway
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
252 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Pirfenidone Pirfenidone 💬Toll-like receptor signaling pathway
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬252. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
253 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Pomalidomide Pomalidomide 💬Toll-like receptor signaling pathway
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬253. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
254 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Siltuximab Siltuximab 💬Toll-like receptor signaling pathway
| Siltuximab | 028 [2] 28, 331 💬254. Toll-like receptor signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
255 | Toll-like receptor signaling pathway 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Sirukumab Sirukumab 💬Toll-like receptor signaling pathway
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
256 | Transcriptional misregulation in cancer 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Olokizumab Olokizumab 💬Transcriptional misregulation in cancer
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
257 | Transcriptional misregulation in cancer 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Pirfenidone Pirfenidone 💬Transcriptional misregulation in cancer
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬257. Transcriptional misregulation in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
258 | Transcriptional misregulation in cancer 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Pomalidomide Pomalidomide 💬Transcriptional misregulation in cancer
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬258. Transcriptional misregulation in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
259 | Transcriptional misregulation in cancer 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Siltuximab Siltuximab 💬Transcriptional misregulation in cancer
| Siltuximab | 028 [2] 28, 331 💬259. Transcriptional misregulation in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
260 | Transcriptional misregulation in cancer 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Sirukumab Sirukumab 💬Transcriptional misregulation in cancer
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
261 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Olokizumab Olokizumab 💬Tuberculosis
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
262 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Pirfenidone Pirfenidone 💬Tuberculosis
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬262. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
263 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Pomalidomide Pomalidomide 💬Tuberculosis
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬263. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
264 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Siltuximab Siltuximab 💬Tuberculosis
| Siltuximab | 028 [2] 28, 331 💬264. Tuberculosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
265 | Tuberculosis 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Sirukumab Sirukumab 💬Tuberculosis
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
266 | Viral protein interaction with cytokine and cytokine receptor 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Olokizumab Olokizumab 💬Viral protein interaction with cytokine and cytokine receptor
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
267 | Viral protein interaction with cytokine and cytokine receptor 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Pirfenidone Pirfenidone 💬Viral protein interaction with cytokine and cytokine receptor
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬267. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
268 | Viral protein interaction with cytokine and cytokine receptor 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Pomalidomide Pomalidomide 💬Viral protein interaction with cytokine and cytokine receptor
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬268. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
269 | Viral protein interaction with cytokine and cytokine receptor 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Siltuximab Siltuximab 💬Viral protein interaction with cytokine and cytokine receptor
| Siltuximab | 028 [2] 28, 331 💬269. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
270 | Viral protein interaction with cytokine and cytokine receptor 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6 [1] IL6 💬TNF signaling pathway
|
Sirukumab Sirukumab 💬Viral protein interaction with cytokine and cytokine receptor
| Sirukumab | 041 [2] 41, 46 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
271 | Viral protein interaction with cytokine and cytokine receptor 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Viral protein interaction with cytokine and cytokine receptor
|
Sarilumab Sarilumab 💬Viral protein interaction with cytokine and cytokine receptor
| Sarilumab | 041 [5] 41, 46, 84, 107, 271 💬271. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
272 | Viral protein interaction with cytokine and cytokine receptor 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Viral protein interaction with cytokine and cytokine receptor
|
Satralizumab Satralizumab 💬Viral protein interaction with cytokine and cytokine receptor
| Satralizumab | 011 [4] 11, 13, 86, 113 💬272. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
273 | Viral protein interaction with cytokine and cytokine receptor 💬 2 genes, 8 drugs (DrugBank) and 35 diseases |
IL6R [1] IL6R 💬Viral protein interaction with cytokine and cytokine receptor
|
Tocilizumab Tocilizumab 💬Viral protein interaction with cytokine and cytokine receptor
| Tocilizumab | 002 [24] 2 , 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 86, 107, 149, 153, 266, 271, 298, 331 💬273. Viral protein interaction with cytokine and cytokine receptor
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
274 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Yersinia infection
|
Olokizumab Olokizumab 💬Yersinia infection
| Olokizumab | 046 [2] 46, 96 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
275 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Yersinia infection
|
Pirfenidone Pirfenidone 💬Yersinia infection
| Pirfenidone | 013 [11] 13, 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬275. Yersinia infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
276 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Yersinia infection
|
Pomalidomide Pomalidomide 💬Yersinia infection
| Pomalidomide | 028 [6] 28, 34, 51, 85, 227, 331 💬276. Yersinia infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
277 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Yersinia infection
|
Siltuximab Siltuximab 💬Yersinia infection
| Siltuximab | 028 [2] 28, 331 💬277. Yersinia infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
278 | Yersinia infection 💬 1 gene, 5 drugs (DrugBank) and 16 diseases |
IL6 [1] IL6 💬Yersinia infection
|
Sirukumab Sirukumab 💬Yersinia infection
| Sirukumab | 041 [2] 41, 46 💬
|
African trypanosomiasis
1 gene, 5 drugs (DrugBank) and 16 diseases
AGE-RAGE signaling pathway in diabetic complications
1 gene, 5 drugs (DrugBank) and 16 diseases
Alcoholic liver disease
1 gene, 5 drugs (DrugBank) and 16 diseases
Alzheimer disease
1 gene, 5 drugs (DrugBank) and 16 diseases
Amoebiasis
1 gene, 5 drugs (DrugBank) and 16 diseases
C-type lectin receptor signaling pathway
1 gene, 5 drugs (DrugBank) and 16 diseases
Cellular senescence
1 gene, 5 drugs (DrugBank) and 16 diseases
Chagas disease
1 gene, 5 drugs (DrugBank) and 16 diseases
Coronavirus disease - COVID-19
2 genes, 8 drugs (DrugBank) and 35 diseases
Cytokine-cytokine receptor interaction
2 genes, 8 drugs (DrugBank) and 35 diseases
Cytosolic DNA-sensing pathway
1 gene, 5 drugs (DrugBank) and 16 diseases
Epstein-Barr virus infection
1 gene, 5 drugs (DrugBank) and 16 diseases
FoxO signaling pathway
1 gene, 5 drugs (DrugBank) and 16 diseases
Graft-versus-host disease
1 gene, 5 drugs (DrugBank) and 16 diseases
Hematopoietic cell lineage
2 genes, 8 drugs (DrugBank) and 35 diseases
Hepatitis B
1 gene, 5 drugs (DrugBank) and 16 diseases
Herpes simplex virus 1 infection
1 gene, 5 drugs (DrugBank) and 16 diseases
HIF-1 signaling pathway
2 genes, 8 drugs (DrugBank) and 35 diseases
Human cytomegalovirus infection
2 genes, 8 drugs (DrugBank) and 35 diseases
Human T-cell leukemia virus 1 infection
1 gene, 5 drugs (DrugBank) and 16 diseases
Hypertrophic cardiomyopathy
1 gene, 5 drugs (DrugBank) and 16 diseases
IL-17 signaling pathway
1 gene, 5 drugs (DrugBank) and 16 diseases
Inflammatory bowel disease
1 gene, 5 drugs (DrugBank) and 16 diseases
Influenza A
1 gene, 5 drugs (DrugBank) and 16 diseases
Insulin resistance
1 gene, 5 drugs (DrugBank) and 16 diseases
Intestinal immune network for IgA production
1 gene, 5 drugs (DrugBank) and 16 diseases
JAK-STAT signaling pathway
2 genes, 8 drugs (DrugBank) and 35 diseases
Kaposi sarcoma-associated herpesvirus infection
1 gene, 5 drugs (DrugBank) and 16 diseases
Legionellosis
1 gene, 5 drugs (DrugBank) and 16 diseases
Lipid and atherosclerosis
1 gene, 5 drugs (DrugBank) and 16 diseases
Malaria
1 gene, 5 drugs (DrugBank) and 16 diseases
Measles
1 gene, 5 drugs (DrugBank) and 16 diseases
NOD-like receptor signaling pathway
1 gene, 5 drugs (DrugBank) and 16 diseases
Non-alcoholic fatty liver disease
2 genes, 8 drugs (DrugBank) and 35 diseases
Pathogenic Escherichia coli infection
1 gene, 5 drugs (DrugBank) and 16 diseases
Pathways in cancer
2 genes, 8 drugs (DrugBank) and 35 diseases
Pathways of neurodegeneration - multiple diseases
1 gene, 5 drugs (DrugBank) and 16 diseases
Pertussis
1 gene, 5 drugs (DrugBank) and 16 diseases
PI3K-Akt signaling pathway
2 genes, 8 drugs (DrugBank) and 35 diseases
Prion disease
1 gene, 5 drugs (DrugBank) and 16 diseases
Rheumatoid arthritis
1 gene, 5 drugs (DrugBank) and 16 diseases
Salmonella infection
1 gene, 5 drugs (DrugBank) and 16 diseases
Th17 cell differentiation
2 genes, 8 drugs (DrugBank) and 35 diseases
TNF signaling pathway
1 gene, 5 drugs (DrugBank) and 16 diseases
Toll-like receptor signaling pathway
1 gene, 5 drugs (DrugBank) and 16 diseases
Transcriptional misregulation in cancer
1 gene, 5 drugs (DrugBank) and 16 diseases
Tuberculosis
1 gene, 5 drugs (DrugBank) and 16 diseases
Viral protein interaction with cytokine and cytokine receptor
2 genes, 8 drugs (DrugBank) and 35 diseases
Yersinia infection
1 gene, 5 drugs (DrugBank) and 16 diseases